凱龍股份(002783.SZ)擬不超8700萬元收購凱樂化工90%股權
格隆匯 12 月 14日丨凱龍股份(002783.SZ)公佈,公司依據《工業和信息化部關於推進民爆行業高質量發展的意見》要求及進一步提高工業炸藥生產能力的戰略目標,經與山東凱樂化工有限公司(“凱樂化工”)進行協商,公司擬以自有資金不超過8700萬元人民幣收購劉春鬥等22名自然人股東所持有佔凱樂化工註冊資本90%的股權。
公司此次股權收購事項是為搶抓行業發展機遇,擴大民爆產品生產能力,通過此次交易,公司的工業炸藥生產能力增加2.835萬噸,合併炸藥產能將突破20萬噸,公司工業炸藥產能排名預計將進入行業前十,公司在民爆行業的地位將進一步得到提升。同時有利於進一步拓寬區域市場佈局,實現對山東市場的整合,進一步拓展業務規模,提升市場競爭能力。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.